R&D Industry Finds Biosimilar Interchangeability Statement By EU Regulators ‘Concerning’
A joint statement from the European Medicines Agency and Heads of Medicines Agencies on biosimilar interchangeability is “concerning,” says Europe’s R&D-based industry federation, EFPIA.
